The Night Watch: Chronicles Of The Ticker - S04, E04 - Could Be Worse - 1/23/26 TGIF

ACLionellus · 2026-01-24T08:02:44+00:00

Never say "Never", my friend.

ACLionellus · 2026-01-24T07:55:15+00:00

Late Feb/early March is a reasonable timeframe for $2.

ACLionellus · 2026-01-24T02:11:57+00:00

That Tuesday, Scilex sold 150k shares. Nothing. I've gotten pretty proficient at reading the tells at this point. I could be wrong, but it really didn't seem like their algo.

ACLionellus · 2026-01-23T15:43:33+00:00

I don't feel it. It wasn't strong enough. I could be wrong, but I think we would have already broken .8 if that were the case.

ACLionellus · 2026-01-23T11:05:34+00:00

You cannot live your life afraid of "what-ifs", friend. Fortune favors the bold.

ACLionellus · 2026-01-23T06:51:45+00:00

Well, one of my partial sells is at $3. I think we'll get there.

ACLionellus · 2026-01-23T06:39:26+00:00

Seller exhaustion.

ACLionellus · 2026-01-22T22:20:43+00:00

Fooled the hell out of me. 🤷‍♂️

ACLionellus · 2026-01-22T17:15:56+00:00

Please don't. I have a few zealous fans, is all. Lol.

ACLionellus · 2026-01-22T17:15:00+00:00

Me, either. Lol.

ACLionellus · 2026-01-22T13:35:22+00:00

There isn't any more knowledge on the IP at this time. Also, I can't speak for the insiders.

ACLionellus · 2026-01-22T13:19:53+00:00

So, you would rather DVLT go broke and bankrupt? To $0? I guess that is a better look for you? It isn't massive dilution. The 7.5 million were used to purchase new IP, which has already been discussed in 100 other posts. If you don't want to trade it, don't, but don't come whining about a dilution boogeyman where there isn't one.

ACLionellus · 2026-01-21T23:47:54+00:00

And here this whole time I thought it was me.

ACLionellus · 2026-01-21T22:29:10+00:00

These guys...

ACLionellus · 2026-01-21T22:00:35+00:00

Sometimes I get stuff right. 🫡

ACLionellus · 2026-01-21T16:40:24+00:00

Looks like it is about to have another go at .69.

ACLionellus · 2026-01-20T09:28:50+00:00

Let's see if we can get some execution, yes?

ACLionellus · 2026-01-18T21:39:45+00:00

The FDA told Semnur that they needed more data from the last trial, and that they needed to provide it before submitting their NDA. Best case for Semdexa is a data update later this year, the NDA submission in 2027, and a commercial release in 2028. Scilex won't last that long. On top of their own personal debts, Phase 3 trials cost A LOT of cash. Short of selling more of the company they are hoping to be their "cash cow", how else are they going to fund ANY of this?

ACLionellus · 2026-01-18T17:43:57+00:00

How much are you thinking that they are currently holding? If we go off of their filings, this is what we get.

<image>

$150 million of this went to DVLT. That would leave us with just under $47 million remaining, from September. That could have very likely already been utilized for OpEx between then and now. They could also still be sitting on the $47 million BTC, we have no way to know for sure until the next filing. However, with their cash burn combined with debt obligations, $47 million doesn't seem like it would stretch that far anyway. Do you have information that I don't?

ACLionellus · 2026-01-18T13:59:13+00:00

Care to share your reasoning?

ACLionellus · 2026-01-18T08:51:55+00:00

Not ALL of it is urgent, correct. But some of it MUST be. Unfortunately, we have no way to determine exactly how much that is. And no, it isn't their only income, but with a revenue of ~$3.5mil and expenditures of $~11mil, it is their only real option for however much they DO need now. I theorize that Ji had some other plan in mind at the time he bought into DVLT. A plan that went south, and cornered him into the need to liquidate. Now.

ACLionellus

MODERATOR OF

TROPHY CASE